Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. 2003

Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
Department of Internal Medicine, Kuopio University Hospital, Kuopio, Finland.

BACKGROUND Interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) levels increase after acute myocardial infarction (AMI) in humans. Experimental data suggest that these cytokines regulate the initiation of scar formation after AMI. We investigated the interrelationships of IL-6 and TNF-alpha, tissue injury, infarct size, cardiac function, and collagen formation in humans. METHODS Serum and plasma samples were taken on 93 patients receiving thrombolytic treatment for their first AMI. Collagen formation was evaluated by measuring concentrations of serum aminoterminal propeptide of type III procollagen (PIIINP). RESULTS IL-6 levels increased by 44% (P<.001) and peaked at 24 hours. Peak IL-6 levels correlated positively with area under the curve of creatine kinase MB mass (r=.31, P<.01), peak troponin T level (r=.34, P<.005), and PIIINP measured at discharge (r=.46, P<.001). There were no changes in TNF-alpha levels, and patients with left ventricular dysfunction (EF<40%) had similar TNF-alpha levels as those with preserved left ventricular function. CONCLUSIONS IL-6 may regulate collagen formation and thus remodeling of the left ventricle after AMI. In addition, TNF-alpha measurement is useless in the assessment of infarct size or left ventricular function during the immediate post-infarction period.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril

Related Publications

Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
February 2010, The journal of obstetrics and gynaecology research,
Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
February 2005, Journal of cardiovascular pharmacology,
Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
December 1989, The Journal of experimental medicine,
Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
October 1997, Zhonghua er bi yan hou ke za zhi,
Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
January 2007, Mediators of inflammation,
Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
October 2005, Indian pediatrics,
Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
January 1997, Methods (San Diego, Calif.),
Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
July 1994, American journal of perinatology,
Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
October 1995, Infection and immunity,
Mikko Puhakka, and Jarkko Magga, and Seppo Hietakorpi, and Ilkka Penttilä, and Paavo Uusimaa, and Juha Risteli, and Keijo Peuhkurinen
October 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology,
Copied contents to your clipboard!